Loading
Hearing Loss / Alzheimer Disease and Related Dementias (ADRD) / Over the counter hearing aid · Interventional Study
ClinicalTrials.gov · August 14, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a registered interventional study—not yet published results—examining whether over-the-counter hearing aids improve communication in patients with concurrent hearing loss and mild cognitive impairment or dementia, compared to communication strategy counseling. No outcomes have been reported in this registry record, so evidence of efficacy or harm cannot be assessed.
Interventional, Randomized, Crossover, Single masking, Treatment purpose. Hearing Loss, Mild Cognitive Impairment, Alzheimer Disease and Related Dementias (ADRD); age from 60 Years; to 90 Years. Intervention: OTC Hearing Aid First; Communication Strategies First. Compared with: Hearing aid and communication strategies are both tested as interventions and implicitly as comparators to each other within the crossover design.. n = 50. 3 sites: United States.
This is a registered interventional study—not yet published results—examining whether over-the-counter hearing aids improve communication in patients with concurrent hearing loss and mild cognitive impairment or dementia, compared to communication strategy counseling. No outcomes have been reported in this registry record, so evidence of efficacy or harm cannot be assessed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is a clinical trial registration with no results reported; the study is actively recruiting and designed to explore whether OTC hearing aids improve communication in patients with concurrent hearing loss and cognitive impairment.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06112860). This is a study registration, not published results. Lead sponsor: Northwestern University. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 50 participants (ESTIMATED). Conditions: Hearing Loss, Mild Cognitive Impairment, Alzheimer Disease and Related Dementias (ADRD). Interventions: DEVICE: Over the counter hearing aid; BEHAVIORAL: Communication Strategies Information/Counseling. Primary outcome measures: Perception of Conversation Index - Dementia Alzheimer's Type (PCI-DAT) , Baseline at enrollment, then after 4 weeks of using each intervention. Brief summary: The goal of this study is to better understand if, in patients with mild to moderate hearing loss who are also experiencing mild cognitive impairment (MCI) or Alzheimer's disease and related dementias (ADRD), Over-the-Counter (OTC) hearing aids: 1. improve communication 2. Whether the magnitude of benefit depends on the patient's level of cognitive disability, 3. Whether alternative remediation (such as targeted communication strategies) offer similar benefits. Participants and a communication partner will be randomized into an OTC first or Communication Strategies first arm, where participants will receive communication strategy information customized for those with cognitive impairment.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.